Skip to main content
Female healthcare professional writes a prescription.

Prescribe Regulora®   

Female healthcare professional writes a prescription.

How to prescribe

Regulora®

For information on how to prescribe Regulora, email info@metamehealth.com

Woman with headphones looks into her tablet.

FOSTERING BETTER
MIND-GUT
COMMUNICATION

GDH has been helping IBS
patients find relief for nearly
four decades.1

Male with earbuds scrolls on his phone.

READY TO
RETHINK IBS PAIN?
.

Consider a safe and effective non-pharmacological option.2-4
.

Male healthcare professional consults with patient.

EDUCATE YOUR
PATIENTS ON THE
BENEFITS OF REGULORA

Get answers to questions
your patients may ask.
.

Line illustration of stack of papers.
HCP AND PATIENT
RESOURCES
Line illustration of paper.
BRIEF SUMMARY
.

JOIN THE REGULORA REVOLUTION

Sign up and stay on the cutting edge of prescription digital therapy.

References:

  1. Donnet AS, Hasan SS, Whorwell PJ. Hypnotherapy for irritable bowel syndrome: patient expectations and perceptions. Therap Adv Gastroenterol. 2022;15:17562848221074208.
  2. Regulora® Instructions for Use for Patients and Physicians. metaMe Health, Inc.; April 2022.
  3. The Rome Foundation. Brain-Gut Psychotherapy Referral Guide. Accessed July 29, 2022. https://theromefoundation.org/wp-content/uploads/Rome-Foundation_GastroPsych-referral-project.pdf
  4. Miller V, Carruthers HR, Morris J, Hasan SS, Archbold S, Whorwell PJ. Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients. Aliment Pharmacol Ther. 2015;41(9):844-855.

IMPORTANT INFORMATION

Regulora® is a prescription-only digital therapeutic device intended to provide behavioral therapy through gut-directed hypnotherapy for adults 22 years of age and older who have been diagnosed with irritable bowel syndrome (IBS). Regulora is indicated as a 3-month treatment for patients with abdominal pain due to IBS and is intended to be used together with other IBS treatments.

US federal law restricts this mobile application device to sale by or on the order of a physician. Regulora is intended for patients who speak and read English. Regulora may not be appropriate for patients with mental or physical impairment that would prevent interacting with a mobile video application. Regulora may not be appropriate for patients with evidence of intestinal illness that better explains IBS symptoms such as celiac disease or inflammatory bowel disease. Regulora should not be used in lieu of your patient’s current IBS medication or therapy. In a clinical trial of Regulora, side effects were low. About 1% of patients experienced abdominal pain, constipation, fatigue, or headache which was thought to be related to using Regulora.

ARE YOU A US HEALTHCARE PROFESSIONAL?

The information provided in this website is
intended for US healthcare professionals only